ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!PPBT Company Profile and Key Details
Purple Biotech Ltd.
PPBT Stock Price Chart
Stock Price Today
Purple Biotech Ltd. (PPBT) stock declined over -3.65%, trading at $3.17 on NASDAQ, down from the previous close of $3.29. The stock opened at $3.23, fluctuating between $3.07 and $3.33 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 1b/2 clinical trials for the treatment of non-small cell lung cancer and pancreatic cancer; and NT219, a small molecule that targets insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment of recurrent and/or metastatic solid tumors and squamous cell carcinoma of the head and neck cancer. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company is headquartered in Rehovot, Israel.
Company Information
| Employees | 20 |
| Beta | 0.33 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | -1% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Purple Biotech Ltd. (NASDAQ: PPBT) stock price is $3.17 in the last trading session. During the trading session, PPBT stock reached the peak price of $3.33 while $3.07 was the lowest point it dropped to. The percentage change in PPBT stock occurred in the recent session was -3.65% while the dollar amount for the price change in PPBT stock was -$0.12.
The NASDAQ listed PPBT is part of Biotechnology industry that operates in the broader Healthcare sector. Purple Biotech Ltd. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Isaac Israel
Acting Chief Executive Officer & Director
Mr. Ido Morpurgo
Vice President Operations
Dr. Michael Schickler Ph.D.
Head of Clinical & Regulatory Affairs
Mr. Gil Efron CPA, M.A.
Chief Executive Officer (Leave of Absence)
Mr. Gil Efron C.P.A., M.A.
Chief Executive Officer
Mr. Nir Livneh
Vice President of Legal Affairs
Dr. Fabien Sebille Ph.D.
Chief Bus. Officer
Mr. Lior Fhima CPA, M.B.A.
Chief Financial Officer
Mr. Ido Morpurgo B.Sc., L.L.M.
Vice President of Operations
Mr. Nir Livneh B.A., L.L.B.
Vice President, Gen. Counsel & Corporation Sec.
PPBT's closing price is 58.5% higher than its 52-week low of $2.00 where as its distance from 52-week high of $20.60 is -84.61%.
Number of PPBT employees currently stands at 20.
Official Website of PPBT is: https://purple-biotech.com
PPBT could be contacted at phone 972 393 33121 and can also be accessed through its website. PPBT operates from 4 Oppenheimer Street, Rehovot, 7670104, Israel.
PPBT stock volume for the day was 6.59K shares. The average number of PPBT shares traded daily for last 3 months was 973.14K.
The market value of PPBT currently stands at $8.39M with its latest stock price at $3.17 and 2.65M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com